期刊文献+

ROC曲线法评价不同指标预测NSCLC放疗后放射性肺炎与食管炎发生的价值 被引量:6

Evaluation Using Receiver-operating Characteristic Curve of thePredictive Value of Influencing Factors of Radiation Pneumonitis and Esophagitis in Non-small Cell Lung CancerPatients Treated with Three-dimensional Conformal Radiotherapy
下载PDF
导出
摘要 目的:探讨非小细胞肺癌(NSCLC)三维适形放射治疗后放射性肺炎与食管炎发生的相关因素,进一步应用ROC曲线评价影响因素预测放射性肺炎与食管炎发生的价值。方法:收集2000年8月至2004年12月符合入组条件接受三维适形放疗的NSCLC患者104例,分析放射性肺炎与食管炎发生的影响因素,采用受试者工作特征(ROC)曲线分析评价其临床诊断性能。结果:患者放射性肺炎发生率为62.6%,≥2级放射性肺炎的发生率为38.3%,单因素分析显示肺内病变的PTV、双肺Dmean、V5、V10、V15、V20、V25、V30、V35及V40对放射性肺炎的发生均有显著性影响,Logistic分析显示双肺V35为影响放射性肺炎发生的独立性因素。ROC曲线分析显示双肺V35预测放射性肺炎的最佳界值为20.75%,敏感度为66.10%,特异性为81.00%;放射性食管炎的发生率为46.2%。单因素分析表明NSCLC病变的GTV、CTV、PTV、食管接受的最大剂量和平均剂量、照射野内的食管体积、食管V40、V45、V50、V55、V60、食管LETT45、LETT50、LETT55、LETT60均与放射性食管炎的发生有关,Logistic分析显示病变的GTV、PTV、食管V60是放射性食管炎发生的独立性影响因素,ROC曲线分析显示病变的GTV、PTV、食管V60预测放射性食管炎的最佳界值分别为124.58cm^3(敏感度为68.75%,特异性为57.15%)、325.50cm^3(敏感度为81.25%,特异性为42.86%)及12.5%(敏感度为81.30%,特异性为69.60%)。结论:双肺V/35和病变的GTV/、PTV、食管V60分别是放射性肺炎与食管炎发生的独立影响因素。 Objective: To explore the correlation of radiation-induced pneumonitis ( RIP ) and esophagitis (RIE) with dosimetric parameters in patients treated with three-dimensional conformal radiation therapy ( 3DCRT ) for non-small cell lung cancer ( NSCLC ). Methods: From August 2000 to December 2004, data from 104 NSCLC patients treated with definitive 3D-CRT were collected. Logis- tical regression analyses were performed to test the association between RIP and the influencing factors. The clinical efficiency was ana- lyzed using the receiver-operating characteristic ( ROC ) curve based on the above analysis. Results: In the study group, the rate of RIP was 62.6%, and the rate of ~〉grade 2 was 38.3%. Univariate analysis showed that the lung mean dose and lung V5-V40 were important factors influencing RIE Multivariable analysis indicated that lung V35 was likely to be an independent factor. The optimal cutoff value for lung V35 was 20.75%, corresponding to a sensitivity of 66.10% and specificity of 81.00% in the ROC curve. Both the gross tumor volume ( GTV ) and planning target volume ( PTV ) of NSCLC, as well as esophagus V60 were also found to be independent parame- ters for predicting RIE. The optimal cutoff value for esophagus V60 was 12.50%, corresponding to a sensitivity of 81.30% and specifici- ty of 69.60% in the ROC curve. There was a significant difference between the areas under the ROC curve of esophagus V60 as well as the GTVs and PTVs of NSCLC ( P 〈 0.05 ). Conclusion: Lung V35 as well as the GTV and PTV of NSCLC are likely to be independent factors in predicting RIE Esophagus V60 is likely to be an independent factor in predicting RIE, respectively.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第16期961-966,共6页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:30870743 30470524) 河北省2010年医学科学研究重点课题计划基金(编号:20100416)资助~~
关键词 非小细胞肺癌 三维适形放 疗放射性肺炎 放射性食管炎 ROC曲线 NSCLC 3D-CRT Radiation pneumonitis Radiation-induced esophagitis ROC curve
  • 相关文献

参考文献11

  • 1Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in non-small--cell lung cancer for three-dimensional conformal radiotherapy planning[J]. IntJ Radiat Oncol Biol Phys, 2000, 48(4): 1015-1024.
  • 2Piotrowski T, Matecka-Nowak M, Milecki P. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small ceU lung cancer after three--dimensional conformal radiotherapy[l]. Neoplasma, 2005, 52(1): 56-62.
  • 3Dang J, Li G, Lu X, et al. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non--small-cell lung cancer treated with three--dimensional conforreal radiotherapy[J]. J Cancer Res Clin Oncol, 2010, 136(8): 1169-1178.
  • 4Hernando ML, Marks LB, Bentel GC, et al. Radiation--hlduced pulmonary toxicity:a dose-volume histogram analysis in 201 patients with lung cancer[J].IntJ Radiat Oncol Biol Phys, 2001, 51(3): 650-659.
  • 5李英,祝淑钗,迟子锋.三维适形放疗肺癌患者的放射性肺炎的相关因素分析[J].肿瘤防治研究,2007,34(8):586-589. 被引量:22
  • 6Rodrigues G, Lock M, D'Souza D, et al. Prediction of radiation pneurnonitis by dose-volume histogram parameters in lung cancer- a systematic review[J]. Radiother Oncol, 2004, 71 (2): 127-138.
  • 7封巍,祝淑钗,翟福山,邱嵘,李娟,王玉祥.三维适形放疗非小细胞肺癌所致食管损伤相关因素分析[J].中华放射肿瘤学杂志,2005,14(2):94-98. 被引量:17
  • 8Kim TH, Cho KH, Pyo HR, et al. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy[J]. IntJ Radiat Oncol Biol Phys, 2005, 62(4): 995-1002.
  • 9Bradley J, Deasy JO, Bentzen S, et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma[J]. IntJ Radiat Oncol Biol Phys, 2004, 58(4): 1106-1113.
  • 10Hirota S, Tsujino K, Endo M, et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatirdpaclitaxel/radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2001, 51(2): 291-295.

二级参考文献24

  • 1Barton M. Tables of equivalent dose in 2 Gy fractions a simple application of linear quadratic formula. Int J Radiat Oncol Biol Phys,1995,31:371-378.
  • 2Maguire PD,Sibley GS,Zhou SM,et al.Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys,1999,45:97-103.
  • 3Hirota S,Tsujino K,Endo M,et al.Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys,2001,51:291-295.
  • 4Singh AK,Lockett MA,Bradley JD,et al.Radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimenional conformal radiotherapy. Int J Radiat Oncol Biol Phys,2003,55:337-341.
  • 5Werner-Wasik M,Pequignot E,Leeper D.Predictors of severe esophagitis include use of concurrent chemotherapy,but not the length of the irradiated esophagus:A multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys,2000,48:689-696.
  • 6Bradley J,Deasy JO,Bentzen S,et al.Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.Int J Radiat Oncol Biol Phys,2004,58:1106-1113.
  • 7Byhardt RW,Scott C,Sause WT,et al. Response,toxicity,failure patterns,and survival in five Radiation Therapy Oncology Group(RTOG)trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys,1998,42:469-478.
  • 8Saunders M,Dische S,Barrett A,et al.Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer:A randomised multicentre trial. Lancet,1997,350:161.
  • 9Barton M.Tables of equivalent dose in 2 Gy fractions a simple application of linear quadratic formula.Int J Radiat Oncol Biol Phys,1995,31:371-378.
  • 10Byhardt RW,Scott C,Sause WT,et al.Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.Int J Radiat Oncol Biol Phys,1998, 42:469-478.

共引文献39

同被引文献66

  • 1陈小平,郑新萍,薛伟珍,冯惠芳.依那普利对放射性心肌损伤cTnT的影响[J].中西医结合心脑血管病杂志,2005,3(2):104-106. 被引量:14
  • 2李英,祝淑钗,迟子锋.三维适形放疗肺癌患者的放射性肺炎的相关因素分析[J].肿瘤防治研究,2007,34(8):586-589. 被引量:22
  • 3Guggino G, Doddoli C, Barlesi F, et al. Completion pneumonectomy in cancae patients : experience with 55 cases[J]. Eur J Cardiothorac Surg,2004,25 (3) : 449 - 455.
  • 4Filopei J,Frishman W.Radiation-induced heart disease.Cardiol Rev,2012,20:184-188.
  • 5Early Breast Cancer Trialists' Collaborative Group(EBCTCG),Darby S,McGale P,et al.Effect of radiotherapy after breast-conserving surgery on 10-yeer recurrence and 15-year breast cancer death:meta-analysis of individual patient data for 10 801 women in 17 randomised trials.Lancet,2011,378:1707-1716.
  • 6Zhang R,Howell RM,Homann K,et al.Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy.Radiat Oncol,2013,8:184.
  • 7Boerma M.Experimental radiation-induced heart disease:past,present,and future.Radiat Res,2012,178:1-6.
  • 8Stewart FA.Mechanisms and dose-response relationships for radiation-induced cardiovascular disease.Ann ICRP,2012,41:72-79.
  • 9谷铣之,殷蔚伯,刘泰福,等.肿瘤放射治疗学.第4版.北京:北京医科大学中国协和医科大学联合出版社,2005:250.
  • 10Johansen S,Tjessem KH,Fossa K,et al.Dose distribution in the heart and cardiac chambers following 4-field radiation therapy of breast cancer:a retrospective study.Breast Cancer(Auckl),2013,7:41-49.

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部